• Welcome
  • Pherecydes Pharma at a glance
  • Press Releases
  • Documentation
    • Documentation
    • Corporate Presentation
    • Financial report
    • Regulated information
      • Shares and voting rights
      • Liquidity contract
      • Share buyback programme
      • Directors’ disclosure
    • Financial operations
  • Shareholders
    • Shareholders
    • General Meeting
      • CSM of December 15, 2022
      • OGM of May 19, 2022
    • Shareholding structure
    • Financial calendar
    • Stock information
    • Analyst coverage
  • Strategic combination
  • Contacts
  • FR
  • EN
Un phage

At the forefront of the fight
against bacterial infections

  • Documentation
  • Corporate Presentation
  • Financial report
  • Regulated information
    • Shares and voting rights
    • Liquidity contract
    • Share buyback programme
    • Directors’ disclosure
  • Financial operations
  • You are here:  
  • Documentation /
  • Financial operations

Financial operations

  • Legal notice
  • Ask us your questions
  • Suscribe to the Newsletter
  • © Pherecydes 2023 - All rights reserved
Z33333